加载中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新数据
US$1.69
−US$0.04 · -2.31%
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
前收盘价
US$1.69
−US$0.04 · -2.31%
盘前
US$1.51
−US$0.18 · -10.65%
10月13日 5:02 ET
盘中时间采用ET。市场数据可能有所延迟。
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
日内区间
当前US$1.69
52周区间
当前US$1.69
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
45
合理估值
情绪
49
多空交织
风险
69
高风险
动量
21
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
日内区间
当前US$1.69
52周区间
当前US$1.69
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CNY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1.16亿 CNY | 1.86亿 CNY | 2.12亿 CNY | 2.6亿 CNY | 2.14亿 CNY |
| 销货成本 | 9249.3万 CNY | 9506.1万 CNY | 8179.6万 CNY | 1.07亿 CNY | 8867.4万 CNY |
| 毛利 | 2386.9万 CNY | 9129.5万 CNY | 1.3亿 CNY | 1.54亿 CNY | 1.25亿 CNY |
| 研究与开发 | 1801.3万 CNY | 1279.4万 CNY | 1190.1万 CNY | 1342.4万 CNY | 1137万 CNY |
| 销售、一般及管理费用 | 7492.4万 CNY | 6384.4万 CNY | 6663.4万 CNY | 6355.8万 CNY | 5819.4万 CNY |
| 营业费用 | 9212.3万 CNY | 7485.6万 CNY | 8486.9万 CNY | 8768.5万 CNY | 7301万 CNY |
| 利息收入 | 9.6万 CNY | 23.1万 CNY | 31.2万 CNY | 11.4万 CNY | 11.2万 CNY |
| 利息支出 | 340万 CNY | 404.3万 CNY | 442.3万 CNY | 283.9万 CNY | 104.6万 CNY |
| 折旧和摊销 | 2595.5万 CNY | 2416.3万 CNY | 2391.2万 CNY | 1880万 CNY | 1601.2万 CNY |
| 营业利润 | −6825.4万 CNY | 1643.9万 CNY | 4498.6万 CNY | 6583.4万 CNY | 5238.3万 CNY |
| 净利润 | −6978.4万 CNY | 1131.1万 CNY | 3145.7万 CNY | 4673.5万 CNY | 3895.9万 CNY |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
